FDA approves iloperidone for acute treatment of bipolar disorder
The US Food and Drug Administration (FDA) has granted approval to iloperidone (Fanapt) for acute treatment of bipolar I disorder. Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009. “Manic or mixed episodes associated with bipolar I disorder are highly […]